PHOTO
Vials with a sticker reading, "COVID-19/ Coronavirus vaccine/ Injection only" and a medical syringe are seen in front of a displayed Moderna logo in this illustration taken October 31, 2020.
Moderna Inc said on Monday it generated about $18.4 billion in COVID-19 vaccine sales in 2022, meeting its forecast of $18 billion-$19 billion for the year.
The company also forecast minimum COVID-19 vaccine sales of about $5 billion in 2023, compared with its previous forecast of $4.5 billion to $5.5 billion in November.
The COVID vaccine maker continues to expect additional contracts for 2023, it said.
(Reporting by Leroy Leo in Bengaluru; Editing by Shinjini Ganguli)